Scopus Biopharma, Inc.

( )
SCPS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
SAVACassava Sciences, Inc. -2.34%46.390.0%$302.06m
VRXValeant Pharmaceuticals International, Inc. 0.81%28.7114.1%$168.93m
HZNPHorizon Therapeutics Plc 0.73%113.705.5%$127.57m
ICLRICON plc -0.45%276.332.8%$116.26m
CTLTCatalent, Inc. -1.17%131.662.0%$100.21m
JAZZJazz Pharmaceuticals Plc 1.16%145.672.1%$95.76m
PRGOPerrigo Co. Plc 0.22%45.756.9%$75.63m
UTHRUnited Therapeutics Corp. 3.17%192.2714.0%$66.45m
ARGXargenx SE 0.15%296.020.0%$53.11m
BHCBausch Health Cos., Inc. 0.81%28.710.0%$43.55m
AXSMAxsome Therapeutics, Inc. 4.31%41.911.8%$42.00m
GRVIGrove, Inc. -15.45%6.460.0%$39.52m
PCRXPacira Biosciences, Inc. 1.12%53.119.8%$32.08m
ENDPEndo International Plc 0.95%4.258.5%$31.56m
RVNCRevance Therapeutics, Inc. 13.94%15.786.1%$28.10m

Company Profile

Scopus Biopharma, Inc. is a biopharmaceutical company, which engages in the development of transformational therapeutics targeting serious diseases with unmet medical needs. Its drug candidates comprises of combination of cannabidiol-mediated, opioid-sparing anesthetics, synthesis of cannabinoids, and cannabinoid receptor mediating compounds for the treatment of systemic sclerosis. The company was founded on April 18, 2017 and is headquartered in New York, NY.